Design, development and optimization of a transungual duple nail lacquer for onychomycosis therapy

被引:4
|
作者
Hasan, N. [1 ]
Singh, M. [1 ]
Sulaiman, S. [1 ]
Nandy, S. [2 ]
Dudeja, M. [2 ]
Ali, A. [1 ]
Iqbal, Z. [1 ]
机构
[1] Jamia Hamdard, SPER, Dept Pharmaceut, New Delhi 110062, India
[2] Jamia Hamdard, Hamdard Inst Med Sci & Res, Dept Microbiol, New Delhi 110062, India
关键词
D O I
10.1111/jdv.14773
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E250 / E251
页数:2
相关论文
共 50 条
  • [41] In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer
    Monti, D
    Saccomani, L
    Chetoni, P
    Burgalassi, S
    Saettone, MF
    Mailland, F
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2005, 31 (01) : 11 - 17
  • [42] Efficacy and safety of ciclopirox nail lacquer 8% solution for the treatment of onychomycosis in diabetic patients
    Seebacher, C
    Nietsch, KH
    Ulbricht, HM
    SKIN AND ENVIRONMENT - PERCEPTION AND PROTECTION, VOLS 1 AND 2, 2001, : 251 - 255
  • [43] Transungual Delivery of Efinaconazole: Its Deposition in the Nail of Onychomycosis Patients and In Vitro Fungicidal Activity in Human Nails
    Sakamoto, Misao
    Sugimoto, Noriaki
    Kawabata, Hideki
    Yamakawa, Eiko
    Kodera, Nobuyuki
    Pillai, Radhakrishnan
    Tatsumi, Yoshiyuki
    JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (11) : 1388 - 1392
  • [44] Antifungal activity of a new ciclopirox water soluble nail lacquer in in vitro models of onychomycosis
    Mailland, F.
    Wenk, J.
    MYCOSES, 2007, 50 (05) : 362 - 362
  • [45] Luliconazole Nail Lacquer for the Treatment of Onychomycosis: Formulation, Characterization and In Vitro and Ex Vivo Evaluation
    Deepa Dehari
    Abhishesh Kumar Mehata
    Vishnu Priya
    Dharmnath Parbat
    Deepak Kumar
    Anand Kumar Srivastava
    Sanjay Singh
    Ashish Kumar Agrawal
    AAPS PharmSciTech, 23
  • [46] Luliconazole Nail Lacquer for the Treatment of Onychomycosis: Formulation, Characterization and In Vitro and Ex Vivo Evaluation
    Dehari, Deepa
    Mehata, Abhishesh Kumar
    Priya, Vishnu
    Parbat, Dharmnath
    Kumar, Deepak
    Srivastava, Anand Kumar
    Singh, Sanjay
    Agrawal, Ashish Kumar
    AAPS PHARMSCITECH, 2022, 23 (06)
  • [47] Evaluating ciclopirox nail lacquer, oral antifungal agents, and other measures in the management of onychomycosis
    Gupta, AK
    CUTIS, 2004, 74 (01): : 4 - 4
  • [48] Design and evaluation of microemulsion-based efinaconazole formulations for targeted treatment of onychomycosis through transungual route: Ex vivo and nail clipping studies
    Agrawal, Vikas
    Patel, Rashmin
    Patel, Mrunali
    Thanki, Kaushik
    Mishra, Sandip
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2021, 201 (201)
  • [49] Onychomycosis Due to Neoscytalidium Treated with Oral Terbinafine, Ciclopirox Nail Lacquer and Nail Abrasion: A Pilot Study of 25 Patients
    Cursi, Igor B.
    Silva, Roberta Teixeira
    Succi, Isabella Brasil
    Bernardes-Engemann, Andrea R.
    Orofino-Costa, Rosane
    MYCOPATHOLOGIA, 2013, 175 (1-2) : 75 - 82
  • [50] Hydroxypropyl chitosan nail lacquer of ciclopirox-PLGA nanocapsules for augmented in vitro nail plate absorption and onychomycosis treatment
    Gaballah, Eman Yahya
    Borg, Thanaa Mohammed
    Mohamed, Elham Abdelmonem
    DRUG DELIVERY, 2022, 29 (01) : 3304 - 3316